Clover Health Investments Corp (CLOV) is a Medicare Advantage insurance company that went public via SPAC merger in January 2021. The company became a meme stock in mid-2021 despite being under investigation by the Department of Justice and a Hindenburg Research short report. CLOV's post-SPAC capital structure carries significant dilution overhang from warrants and ongoing equity financing.
The DilutionWatch score for CLOV updates automatically as new SEC filings appear. View the live CLOV score →
Clover Health merged with Chamath Palihapitiya's Social Capital Hedosophia Holdings Corp VI in January 2021. Like most SPAC mergers of this era, the transaction included warrant issuance and founder shares. Post-merger, Clover maintained a complex capital structure with Class A (public) and Class B (founder/management) shares, creating voting dilution alongside economic dilution.
Clover Health's profitability has been a moving target — the company has made progress on its medical loss ratio and administrative costs, but check the most recent 10-Q for current profitability status. Insurance companies' financial health is most accurately assessed through medical loss ratio (MLR) and administrative expense trends alongside traditional cash flow metrics.
CLOV has warrants outstanding from its SPAC merger and potentially from subsequent financing transactions. The warrant count and strike prices are disclosed in 10-K footnotes. DilutionWatch's warrant tracker shows the current warrant overhang as a percentage of outstanding shares.
Monitor CLOV SEC filings and get instant alerts. Free for 3 tickers — no credit card required.
Set Up CLOV Alert Free →